Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Brief Summary

GUIDELINE TITLE

Capnography/capnometry during mechanical ventilation: 2003 revision and update.

BIBLIOGRAPHIC SOURCE(S)

GUIDELINE STATUS

This is the current release of the guideline.

This guideline updates a previous version: American Association for Respiratory Care (AARC). AARC clinical practice guideline. Capnography/capnometry during mechanical ventilation. Respir Care 1995 Dec;40(12):1321-4.

BRIEF SUMMARY CONTENT

 
RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

 Go to the Complete Summary

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

Description/Definition

For purposes of this guideline, capnography refers to the evaluation of carbon dioxide concentrations [CO2] in the respiratory gases of mechanically ventilated patients. A capnographic device incorporates one of two types of analyzers: mainstream or sidestream. Mainstream analyzers insert a sampling window into the ventilator circuit for measurement of CO2, whereas a sidestream analyzer aspirates gas from the ventilator circuit, and the analysis occurs away from the ventilator circuit. Analyzers utilize infrared, mass or Raman spectra, or a photoacoustic spectra technology. Flow measuring devices are utilized in volume-based capnographs.

Setting

This procedure may be performed by trained health care personnel in any setting in which mechanically ventilated patients are found--for example, the hospital, the extended care facility, or during transport.

Indications

On the basis of available evidence, capnography should not be mandated for all patients receiving mechanical ventilatory support, but it may be indicated for:

  • Evaluation of the exhaled CO2, especially end-tidal CO2, which is the maximum partial pressure of CO2 exhaled during a tidal breath (just prior to the beginning of inspiration) and is designated PetCO2
  • Monitoring severity of pulmonary disease and evaluating response to therapy, especially therapy intended to improve the ratio of dead space to tidal volume (VD/VT) and the matching of ventilation to perfusion (V/Q), and, possibly, to increase coronary blood flow
  • Use as an adjunct to determining that tracheal rather than esophageal intubation has taken place (Low or absent cardiac output may negate its use for this indication); colorimetric CO2 detectors are adequate devices for this purpose
  • Continued monitoring of the integrity of the ventilatory circuit, including the artificial airway
  • Evaluation of the efficiency of mechanical ventilatory support by determination of the difference between the arterial partial pressure for CO2 (PaCO2) and the PetCO2
  • Monitoring adequacy of pulmonary, systemic, and coronary blood flow
    • Estimation of effective (nonshunted) pulmonary capillary blood flow by a partial rebreathing method
    • Use as an adjunctive tool to screen for pulmonary embolism (Evidence for the utility of dead space determinations as a screening tool for pulmonary embolism is, at present, not conclusive.)
    • Monitoring the matching of ventilation to perfusion during independent lung ventilation for unilateral pulmonary contusion
  • Monitoring inspired CO2 when CO2 gas is being therapeutically administered
  • Graphic evaluation of the ventilator-patient interface. Evaluation of the capnogram may be useful in detecting rebreathing of CO2, obstructive pulmonary disease, waning neuromuscular blockade ('curare cleft'), cardiogenic oscillations, esophageal intubation, cardiac arrest, and contamination of the monitor or sampling line with secretions or mucus.
  • Measurement of the volume of CO2 elimination to assess metabolic rate and/or alveolar ventilation

Contraindications

There are no absolute contraindications to capnography in mechanically ventilated patients provided that the data obtained are evaluated with consideration given to the patient’s clinical condition.

Limitations

Capnography, when performed using a device calibrated and operated as recommended by the manufacturer, has few limitations. It is important to note that although the capnograph provides valuable information about the efficiency of ventilation (as well as pulmonary and coronary perfusion), it is not a replacement or substitute for assessing the PaCO2. The difference between PetCO2 and PaCO2 increases as dead-space volume increases. In fact, the difference between the PaCO2 and PetCO2 has been shown to vary within the same patient over time. Alterations in breathing pattern and tidal volume may introduce error into measurements designed to be made during stable, steady-state conditions. Interpretation of results must take into account the stability of physiologic parameters such as minute ventilation, tidal volume, cardiac output, ventilation/perfusion ratios and CO2 body stores.

Certain situations may affect the reliability of the capnogram. The extent to which the reliability is affected varies somewhat among types of devices (infrared, photoacoustic, mass spectrometry, and Raman spectrometry). Limitations include:

  • The composition of the respiratory gas mixture may affect the capnogram (depending on the measurement technology incorporated).
    • The infrared spectrum of CO2 has some similarities to the spectra for both oxygen and nitrous oxide. High concentrations of either or both oxygen or nitrous oxide may affect the capnogram, and, therefore, a correction factor should be incorporated into the calibration of any capnograph used in such a setting.
    • The reporting algorithm of some devices (primarily mass spectrometers) assumes that the only gases present in the sample are those that the device is capable of measuring. When a gas that the mass spectrometer cannot detect (such as helium) is present, the reported values of CO2 are incorrectly elevated in proportion to the concentration of helium present.
  • The breathing frequency may affect the capnograph. High breathing frequencies may exceed the response capabilities of the capnograph. In addition, the breathing frequency, above 10 breaths/min, has been shown to affect devices differently.
  • The presence of Freon (used as a propellant in metered dose inhalers) in the respiratory gas has been shown to artificially increase the CO2 reading of mass spectrometers (i.e., to show an apparent increase in [CO2]). A similar effect has not yet been demonstrated with Raman or infrared spectrometers.
  • Contamination of the monitor or sampling system by secretions or condensate, a sample tube of excessive length, a sampling rate that is too high, or obstruction of the sampling chamber can lead to unreliable results.
  • Use of filters between the patient airway and the sampling line of the capnograph may lead to lowered PetCO2 readings.
  • Low cardiac output may cause a false negative result when attempting to verify endotracheal tube (ETT) position in the trachea. False positive results have been reported with ETT position in the pharynx and when antacids and/or carbonated beverages are present in the stomach.
  • Decreased tidal volume delivery is possible during volume modes, some dual control modes, and time-cycled pressure limited ventilation with low continuous flowrates if the sampling flowrate of a sidestream analyzer is too high, especially in neonates and pediatrics.
  • Inaccurate measurement of expired CO2 may be caused by leaks of gas from the patient/ventilator system preventing collection of expired gases, including
    • Leaks in the ventilator circuit
    • Leaks around tracheal tube cuffs or uncuffed tubes

Assessment of Need

Capnography is considered a standard of care during anesthesia. The American Society of Anesthesiologists has suggested that capnography be available for patients with acute ventilatory failure on mechanical ventilatory support. The American College of Emergency Physicians recommends capnography as an adjunctive method to ensure proper endotracheal tube (ETT) position. The international guidelines for emergency cardiovascular care recommend use of capnography to verify endotracheal tube placement in all age groups. Assessment of the need to use capnography with a specific patient should be guided by the clinical situation. The patient's primary cause of respiratory failure and the acuteness of his or her condition should be considered.

Resources

  • Equipment: The capnograph and accessories (e.g., airway adapter, sampling tube, depending on capnograph). The capnograph should be calibrated as recommended by the manufacturer.
  • Personnel: Licensed or credentialed respiratory care practitioners or individuals with similar credentials (e.g., MD, RN) who have the necessary training and demonstrated skills to correctly calibrate and evaluate the capnograph, assess the patient and the patient-ventilator system, and the ability to exercise appropriate clinical judgment.

Monitoring

During capnography the following should be considered and monitored:

  • Ventilatory variables: tidal volume, respiratory rate, positive end-expiratory pressure, inspiratory-to-expiratory time ratio (I:E), peak airway pressure, and concentrations of respiratory gas mixture
  • Hemodynamic variables: systemic and pulmonary blood pressures, cardiac output, shunt, and ventilation-perfusion imbalances.

Frequency

Capnography (or, at least, capnometry) should be available during endotracheal intubation. Capnography is not indicated for every mechanically ventilated patient; however, when it is used, the measurement period should be long enough to allow determination of the PaCO2-PetCO2 difference, note changes in PaCO2-PetCO2 difference as a result of therapy, and allow interpretation of observed trends.

Infection Control

No specific precautions are necessary, although Standard Precautions (as described by the Centers for Disease Control and Prevention) and precautions designed to limit the spread of tuberculosis should always be implemented during patient care.

  • The sensor (the portion of the device contacting the patient's airway) should be subjected to high-level disinfection between patients, according to the manufacturer's recommendations.
  • The monitor (the portion not contacting the patient or the patient's airway) should be cleaned as needed, according to manufacturer's recommendations.

CLINICAL ALGORITHM(S)

None provided

EVIDENCE SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

The type of evidence supporting each recommendation is not specifically stated. The guideline is developed from a thorough review of the literature, surveys of current practice, and the expertise of the members of the Working Group.

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

ADAPTATION

Not applicable: The guideline was not adapted from another source.

DATE RELEASED

1995 Dec (revised 2003)

GUIDELINE DEVELOPER(S)

American Association for Respiratory Care - Professional Association

SOURCE(S) OF FUNDING

American Association for Respiratory Care (AARC)

GUIDELINE COMMITTEE

Mechanical Ventilation Focus Group

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Primary Author: Charles P. McArthur, RRT, RPFT

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

Not stated

GUIDELINE STATUS

This is the current release of the guideline.

This guideline updates a previous version: American Association for Respiratory Care (AARC). AARC clinical practice guideline. Capnography/capnometry during mechanical ventilation. Respir Care 1995 Dec;40(12):1321-4.

GUIDELINE AVAILABILITY

Electronic copies: Available in Portable Document Format (PDF) from the American Association for Respiratory Care (AARC) Web site.

Print copies: Available from the American Association for Respiratory Care (AARC), CPG Desk, 11030 Ables Ln, Dallas, TX 75229-4593; Web site: www.aarc.org.

AVAILABILITY OF COMPANION DOCUMENTS

None available

PATIENT RESOURCES

None available

NGC STATUS

This summary was completed by ECRI on November 30, 1998. The information was verified by the guideline developer on December 15, 1998. This summary was updated by ECRI on August 20, 2003.

COPYRIGHT STATEMENT

This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions.

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo